Gene: ENKD1
Official Full Name: enkurin domain containing 1provided by HGNC
Gene Summary: Enables alpha-tubulin binding activity and microtubule binding activity. Involved in establishment of mitotic spindle orientation and non-motile cilium assembly. Located in microtubule cytoskeleton. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25204 | ENKD1 Knockout cell line (HeLa) | Human | ENKD1 | 1:3~1:6 | Negative | Online Inquiry |
KO25205 | ENKD1 Knockout cell line (HCT 116) | Human | ENKD1 | 1:2~1:4 | Negative | Online Inquiry |
KO25206 | ENKD1 Knockout cell line (HEK293) | Human | ENKD1 | 1:3~1:6 | Negative | Online Inquiry |
KO25207 | ENKD1 Knockout cell line (A549) | Human | ENKD1 | 1:3~1:4 | Negative | Online Inquiry |
ENKD1 Gene Knockout Cell Lines are genetically engineered cell lines where the ENKD1 gene has been specifically disrupted or inactivated. This innovation provides researchers with invaluable tools to dissect the biological roles of the ENKD1 gene in various cellular processes and disease states. Through CRISPR-Cas9 technology or other gene-editing methods, these knockout cell lines create a cellular model to observe the impact of ENKD1 loss, thereby elucidating pathways involved in cell proliferation, signaling, and apoptosis.
The primary mechanism of these knockout cell lines hinges on the precise editing of the ENKD1 gene, leading to either a complete gene failure or a significant reduction in function. This allows for a clearer understanding of how the absence of ENKD1 can influence cellular behavior and its potential implication in diseases, including cancer and metabolic disorders. Researchers can utilize these models to test hypotheses, screen therapeutic compounds, and evaluate potential gene therapies in a controlled environment.
Scientifically, ENKD1 Gene Knockout Cell Lines offer critical insights into important biological functions and their implications in human health. Their use in both basic research and clinical applications presents opportunities for significant advancements in targeting ENKD1 in therapeutic contexts. Such research could potentially lead to novel treatment strategies, particularly in oncology.
Compared to alternatives, these knockout cell lines provide a highly specific and reproducible system for studying gene function, allowing for high-throughput screening, reduced background variability, and more accurate modeling of disease mechanisms. Additionally, they support rapid experimental turnover, thereby accelerating the pace of research.
For researchers and clinicians invested in understanding the multifaceted roles of the ENKD1 gene, these knockout cell lines offer an unmatched resource. As an organization committed to advancing genetic research, we harness cutting-edge technology and expert biological insights to deliver high-quality cell lines that empower scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.